Anti-Dyskinesia Agents
2 clinical trials · Condition
◉ Watch Anti-Dyskinesia Agents
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias (NCT01491529) | Novartis Pharmaceuticals | 2012-04-01 |
| Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias (NCT01491932) | Novartis Pharmaceuticals | 2012-03-01 |
Track Anti-Dyskinesia Agents automatically
Every clearance here is in the API, with alerts when new ones post.